1 |
Statistics Korea. Annual Report on The Causes of Death Statistics. available from http://kostat.go.kr/portal/korea/kor_nw/2/6/2/index.board (Korean)
|
2 |
Mohan KM, Wolfe CD, Rudd AG, Heuschmann PU, Kolominsky-Rabas PL, Grieve AP. Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis. Stroke 2011;42(5):1489-1494
DOI
ScienceOn
|
3 |
Antiplatelet Trialist's Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. BMJ 1988;296(6618):320-331
DOI
|
4 |
Antiplatelet Trialist's Collaboration. Collaborative overview of randomized trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308(6921):81-106
DOI
|
5 |
Ovbiagele B, Saver JL, Fredieu A, Suzuki S, Selco S, Rajajee V, McNair N, Razinia T, Kidwell CS. In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke 2004;35(12):2879-2883
DOI
|
6 |
Rahiman A, Saver JL, Porter V, Buxton W, McNair N, Razinia T, Ovbiagele B. In-hospital initiation of secondary prevention is associated with improved vascular outcomes at 3 months. J Stroke Cerebrovasc Dis 2008;17(1):5-8
DOI
|
7 |
Bushnell C, Zimmer L, Schwamm L, Goldstein LB, Clapp-Channing N, Harding T, Drew L, Zhao X, Peterson E; AVAIL registry. The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) registry: design, rationale, and baseline patient characteristics. Am Heart J 2009;157(3):428-435
DOI
|
8 |
Bushnell CD1, Olson DM, Zhao X, Pan W, Zimmer LO, Goldstein LB, Alberts MJ, Fagan SC, Fonarow GC, Johnston SC, Kidwell C, Labresh KA, Ovbiagele B, Schwamm L, Peterson ED; AVAIL Investigators. Secondary preventive medication persistence and adherence 1 year after stroke. Neurology 2011;77(12):1182-905.
DOI
|
9 |
Lehane E, McCarthy G. Intentional and unintentional medication non-adherence: A comprehensive framework for clinical research and practice? A discussion paper. Int J Nurs Stud 2007;44(8):1468-77
DOI
|
10 |
Hugtenburg JG, Timmers L, Elders PJ, Vervloet M, van Dijk L. Definitions, variants, and causes of nonadherence with medication: A challenge for tailored interventions. Patient Prefer Adherence 2013;7:675
|
11 |
Wroe AL. Intentional and unintentional nonadherence: A study of decision making. J Behav Med 2002;25(4):355-372
DOI
|
12 |
Lowry KP, Dudley TK, Oddone EZ, Bosworth HB. Intentional and unintentional nonadherence to antihypertensive medication. Ann Pharmacother 2005;39(7-8):1198-1203
DOI
|
13 |
Lehane E, McCarthy G. An examination of the intentional and unintentional aspects of medication non-adherence in patients diagnosed with hypertension. J Clin Nurs 2007; 16(4):698-706
DOI
|
14 |
Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLoS One 2013;8(12):e80633
DOI
|
15 |
Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999;47(6):555-567.
DOI
|
16 |
Kang H. A guide on the use of factor analysis in the assessment of construct validity. J Korean Acad Nurs 2013;43(5):587-594 (Korean)
DOI
ScienceOn
|
17 |
Jung JH, Kim YH, Han DJ, Kim KS, Chu SH. Medication Adherence in Patients Taking Immunosuppressants after Kidney Transplantation. J Korean Soc Transplant 2010;24(4):289-297 (Korean)
DOI
|
18 |
Lee JK. Factors associated with drug misuse behaviors among polypharmacy elderly. Korean J Adult Nurs 2011;23(6):554-563 (Korean)
|
19 |
Hong KS. Measuring and analysis of outcome in stroke trials. Korean J Stroke 2011;13(1):1-10 (Korean)
DOI
|
20 |
Lubben J1, Blozik E, Gillmann G, Iliffe S, von Renteln Kruse W, Beck JC, Stuck AE. Performance of an abbreviated version of the Lubben Social Network Scale among three European community-dwelling older adult populations. Gerontologist 2006;46(4):503-513.
DOI
|
21 |
Hong M, Casado BL, Harrington D. Validation of Korean versions of the Lubben social network scales in Korean Americans. Clinical gerontologist 2011;34(4):319-334
DOI
|
22 |
Ki BS. A preliminary study for the standardization of geriatric depression scale short form-Korea version. J Korean Neuropsychatr Assoc 1996;35(2):298-307 (Korean)
|
23 |
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353(5):487-497
DOI
|
24 |
Koh IS, Kim HC, Kwon SB, Hwang SH, Kwon KH, Kim SM, Song HK, Lee BC. The compliance of stroke patients for secondary prevention : In Seoul & Kyunggi Province J Kor Neurol Ass 1999;17(4):472-477 (Korean)
|
25 |
Lummis HL1, Sketris IS, Gubitz GJ, Joffres MR, Flowerdew GJ. Medication persistence rates and factors associated with persistence in patients following stroke: a cohort study. BMC Neurol 2008;8:25
DOI
|
26 |
Ji R, Liu G, Shen H, Wang Y, Li H, Peterson E, Wang Y. Persistence of secondary prevention medications after acute ischemic stroke or transient ischemic attack in Chinese population: data from China National Stroke Registry. Neurol Res 2013;35(1):29-36
DOI
ScienceOn
|
27 |
Jang SH, Kang PS, Lee KS, Kim SB, Yun SH. Change in health behaviors of patients before and after stroke. Korean J of Rural Med 2002;27(1):9-19 (Korean)
|
28 |
Kim SO. Medication adherence of elderly with hypertension and/or diabetes-mellitus and its' influencing factors. Kor J Clin Pharm 2011;21(2):81-89 (Korean)
|
29 |
Kirkpatrick AC, Vincent AS, Guthery L, Prodan CI. Cognitive impairment is associated with medication nonadherence in asymptomatic carotid stenosis. Am J Med 2014;127(12):1243-1246
DOI
|
30 |
DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160(14):2101-2107
DOI
|
31 |
Leventhal H, Weinman J, Leventhal EA, Phillips LA. Health psychology: The search for pathways between behavior and health. Annu Rev Psychol 2008;59:477-505
DOI
|